Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5376)
Solid Biosciences Inc. (SLDB)
Cumbo Alexander — Director
Shares
16,644
Price
$5.82
Total Value
$96.92K
Shares Held After
235,405
% of Holdings
6.6%
JOHNSON & JOHNSON (JNJ)
Schmid Timothy — EVP, WW Chair, MedTech
Shares
8,998
Price
$244.53
Total Value
$2.20M
Shares Held After
26,769
% of Holdings
25.2%
JOHNSON & JOHNSON (JNJ)
Schmid Timothy — EVP, WW Chair, MedTech
Shares
13,625
Price
$244.20
Total Value
$3.33M
Shares Held After
26,769
% of Holdings
33.7%
Solid Biosciences Inc. (SLDB)
Brooks Gabriel — Chief Medical Officer
Shares
0
Price
$5.82
Total Value
$0.00
Shares Held After
89,466
% of Holdings
0.0%
Solid Biosciences Inc. (SLDB)
Tan Kevin — CFO & Treasurer
Shares
5,404
Price
$5.82
Total Value
$31.47K
Shares Held After
99,422
% of Holdings
5.2%
Solid Biosciences Inc. (SLDB)
Howton David T — Chief Operating Officer
Shares
7,469
Price
$5.82
Total Value
$43.49K
Shares Held After
105,077
% of Holdings
6.6%
Solid Biosciences Inc. (SLDB)
Ganot Ilan — Director
Shares
2,658
Price
$5.82
Total Value
$15.48K
Shares Held After
27,474
% of Holdings
8.8%
Solid Biosciences Inc. (SLDB)
Herzich Paul — Chief Technology Officer
Shares
3,616
Price
$5.82
Total Value
$21.06K
Shares Held After
72,638
% of Holdings
4.7%
Solid Biosciences Inc. (SLDB)
Hanrahan Jessie — Chief Regulatory Officer
Shares
4,134
Price
$5.82
Total Value
$24.07K
Shares Held After
74,318
% of Holdings
5.3%
Adagio Therapeutics, Inc. (ADGI)
Andersen Jill — Chief Legal Officer, Secretary
Shares
34,939
Price
$1.58
Total Value
$55.13K
Shares Held After
181,736
% of Holdings
16.1%
Adagio Therapeutics, Inc. (ADGI)
Lee Timothy Edward — Chief Commercial Officer
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
117,717
% of Holdings
15.1%
EXELIXIS, INC. (EXEL)
Hefti Brenda — SVP and General Counsel
Shares
18,669
Price
$44.01
Total Value
$821.62K
Shares Held After
96,512
% of Holdings
16.2%
Adagio Therapeutics, Inc. (ADGI)
Duke William E. — Chief Financial Officer
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
107,717
% of Holdings
16.3%
Adagio Therapeutics, Inc. (ADGI)
Green Julie — Chief Human Resources Officer
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
107,717
% of Holdings
16.3%
Adagio Therapeutics, Inc. (ADGI)
Allen Robert D. III — Chief Scientific Officer
Shares
19,392
Price
$1.58
Total Value
$30.60K
Shares Held After
114,487
% of Holdings
14.5%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
216
Price
$51.97
Total Value
$11.23K
Shares Held After
36,680
% of Holdings
0.6%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,824
Price
$51.38
Total Value
$350.60K
Shares Held After
36,896
% of Holdings
15.6%
Avista Public Acquisition Corp. II (AHPA)
Berkman Charles S — Chief Legal Officer
Shares
9,673
Price
$1.71
Total Value
$16.54K
Shares Held After
392,700
% of Holdings
2.4%
HCA Healthcare, Inc. (HCA)
McAlevey Michael R — EVP & Chief Legal & Admin Off.
Shares
1,694
Price
$533.37
Total Value
$903.54K
Shares Held After
8,853
% of Holdings
16.1%
Avista Public Acquisition Corp. II (AHPA)
FOEHR MATTHEW W — Director
Shares
30,843
Price
$1.71
Total Value
$52.74K
Shares Held After
4,403,277
% of Holdings
0.7%
Avista Public Acquisition Corp. II (AHPA)
GUSTAFSON KURT A — Executive VP, Finance and CFO
Shares
9,301
Price
$1.71
Total Value
$15.90K
Shares Held After
268,851
% of Holdings
3.3%
BECTON DICKINSON & CO (BDX)
SCOTT BERTRAM L — Director
Shares
953
Price
$182.61
Total Value
$174.03K
Shares Held After
36,763
% of Holdings
2.5%
CVRx, Inc. (CVRX)
Jain Mudit K. — Director
Shares
600
Price
$4.64
Total Value
$2.79K
Shares Held After
5,650
% of Holdings
10.6%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
133,688
Price
$1.32
Total Value
$176.47K
Shares Held After
1,654,186
% of Holdings
8.1%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
2,370
Price
$116.18
Total Value
$275.35K
Shares Held After
16,321
% of Holdings
12.7%
Cardinal Health, Inc. (CAH)
Alt Aaron E — Chief Financial Officer
Shares
2,328
Price
$225.50
Total Value
$524.96K
Shares Held After
26,408
% of Holdings
8.1%
Dermata Therapeutics, Inc. (DRMA)
Bedoya-Toro Munera Maria E — SVP, Regulatory Affairs
Shares
1,000
Price
$1.27
Total Value
$1.27K
Shares Held After
1,012
% of Holdings
98.8%
Aveanna Healthcare Holdings, Inc. (AVAH)
Shaner Jeff — Chief Executive Officer
Shares
119,884
Price
$7.65
Total Value
$916.53K
Shares Held After
2,992,917
% of Holdings
3.9%
Aveanna Healthcare Holdings, Inc. (AVAH)
Buckhalter Matthew — Chief Financial Officer
Shares
9,351
Price
$7.65
Total Value
$71.49K
Shares Held After
555,922
% of Holdings
1.7%
Aveanna Healthcare Holdings, Inc. (AVAH)
Cunningham Patrick A. — Chief Compliance Officer
Shares
12,759
Price
$7.65
Total Value
$97.54K
Shares Held After
374,156
% of Holdings
3.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
Stewart Deborah — SVP, Chief Accounting Officer
Shares
7,738
Price
$7.65
Total Value
$59.16K
Shares Held After
323,884
% of Holdings
2.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
Reisz Edwin C. — Chief Administrative Officer
Shares
42,057
Price
$7.65
Total Value
$321.53K
Shares Held After
1,567,043
% of Holdings
2.6%
Outset Medical, Inc. (OM)
Brottem John L. — General Counsel
Shares
2,842
Price
$3.35
Total Value
$9.52K
Shares Held After
32,935
% of Holdings
7.9%
Outset Medical, Inc. (OM)
Trigg Leslie — Director
Shares
3,361
Price
$3.35
Total Value
$11.26K
Shares Held After
102,342
% of Holdings
3.2%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
200
Price
$103.84
Total Value
$20.77K
Shares Held After
114,897
% of Holdings
0.2%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,069
Price
$103.00
Total Value
$110.11K
Shares Held After
115,097
% of Holdings
0.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
900
Price
$101.70
Total Value
$91.53K
Shares Held After
116,166
% of Holdings
0.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
200
Price
$100.52
Total Value
$20.10K
Shares Held After
117,066
% of Holdings
0.2%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,200
Price
$99.42
Total Value
$119.30K
Shares Held After
117,266
% of Holdings
1.0%
Outset Medical, Inc. (OM)
Nash Marc — EVP Operations R&D & Service
Shares
1,817
Price
$3.35
Total Value
$6.09K
Shares Held After
39,988
% of Holdings
4.3%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Farmer Michele — See Remarks
Shares
35,215
Price
$1.58
Total Value
$55.50K
Shares Held After
234,044
% of Holdings
13.1%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Van Oene Mark — See Remarks
Shares
129,790
Price
$1.58
Total Value
$204.55K
Shares Held After
1,797,745
% of Holdings
6.7%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
HENRY CHRISTIAN O — See Remarks
Shares
331,793
Price
$1.58
Total Value
$522.91K
Shares Held After
2,814,374
% of Holdings
10.5%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
2,200
Price
$29.59
Total Value
$65.11K
Shares Held After
387,075
% of Holdings
0.6%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
5,400
Price
$28.95
Total Value
$156.33K
Shares Held After
389,275
% of Holdings
1.4%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
900
Price
$28.02
Total Value
$25.22K
Shares Held After
394,675
% of Holdings
0.2%
EXELIXIS, INC. (EXEL)
Smith Julie — Director
Shares
42,422
Price
$43.33
Total Value
$1.84M
Shares Held After
20,590
% of Holdings
67.3%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
45,000
Price
$26.17
Total Value
$1.18M
Shares Held After
25,000
% of Holdings
64.3%
Enliven Therapeutics, Inc. (ELVN)
Heyman Richard A. — Director
Shares
1,230
Price
$26.18
Total Value
$32.20K
Shares Held After
22,647
% of Holdings
5.2%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
40
Price
$629.86
Total Value
$25.19K
Shares Held After
12,693
% of Holdings
0.3%
Showing 2451–2500 of 5376 transactions (page 50 of 108)